A combined biomarker pattern improves the discrimination of lung cancer

References

• Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr. (2002). Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 62:3609–14.
   PubMed Web of Science ®Google Scholar
• Altland K, Winter P. (2003). Polyacrylamide gel electrophoresis followed by sodium dodecyl sulfate gradient polyacrylamide gel electrophoresis for the study of the dimer to monomer transition of human transthyretin. Electrophoresis 24:2265–71.
   PubMed Web of Science ®Google Scholar
• Basu TK, Sasmal P. (1988). Plasma vitamin A, retinol-binding protein, and prealbumin in postoperative breast cancer patients. Int J Vitam Nutr Res 58:281–3.
   PubMedGoogle Scholar
• Bausserman LL, Herbert PN, Rodge R, Nicolosi RJ. (1984). Rapid clearance of serum amyloid A from high-density lipoproteins. Biochim Biophys Acta 792:186–91.
   PubMed Web of Science ®Google Scholar
• Benson MD, Cohen AS. (1979). Serum amyloid A protein in amyloidosis, rheumatic and neoplastic diseases. Arthritis Rheum 22:36–42.
   PubMed Web of Science ®Google Scholar
• Bergen HR, Zeldenrust SR, Butz ML, Snow DS, Dyck PJ, Dyck PJ, Klein CJ, O’Brien JF, Thibodeau SN, Muddiman DC. (2004). Identification of transthyretin variants by sequential proteomic and genomic analysis. Clin Chem 50:1544–52.
   PubMed Web of Science ®Google Scholar
• Chen G, Gharib TG, Wang H, Huang CC, Kuick R, Thomas DG, Shedden KA, Misek DE, Taylor JM, Giordano TJ, Kardia SL, Iannettoni MD, Yee J, Hogg PJ, Orringer MB, Hanash SM, Beer DG. (2003). Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci U S A 100:13537–42.
   PubMed Web of Science ®Google Scholar
• Chen YD, Zheng S, Yu JK, Hu X. (2004). Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res 10:8380–5.
   PubMed Web of Science ®Google Scholar
• Cho WC, Yip TT, Yip C, Yip C, Yip V, Thulasiraman V, Ngan RK, Yip TT, Lau WH, Au JS, Law SC, Cheng WW, Ma VW, Lim CK. (2004). Identification of serum amyloid A protein as a potential useful biomarkers to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clinical Cancer Research 10:43–52.
   PubMed Web of Science ®Google Scholar
• d’Eril GM, Anesi A, Maggiore M, Leoni V. (2001). Biological variation of serum amyloid A in healthy subjects. Clin Chem 47:1498–9.
   PubMed Web of Science ®Google Scholar
• Ellegård LH, Bosaeus IG. (2008). Biochemical indices to evaluate nutritional support for malignant disease. Clin Chim Acta 390:23–7.
   PubMedGoogle Scholar
• Fung ET, Yip TT, Lomas L, Wang Z, Yip C, Meng XY, Lin S, Zhang F, Zhang Z, Chan DW, Weinberger SR. (2005). Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Int J Cancer 115:783–9.
   PubMed Web of Science ®Google Scholar
• Gericke B, Raila J, Sehouli J, Haebel S, Könsgen D, Mustea A, Schweigert FJ. (2005). Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients. BMC Cancer 5:133.
   PubMed Web of Science ®Google Scholar
• Glojnaric I, Casl MT, Simic D, Lukac J. (2001). Serum amyloid A protein (SAA) in colorectal carcinoma. Clin Chem Lab Med 39:129–33.
   PubMedGoogle Scholar
• Granville CA, Dennis PA. (2005). An overview of lung cancer genomics and proteomics. Am J Respir Cell Mol Biol 32:169–76.
   PubMed Web of Science ®Google Scholar
• Howard BA, Wang MZ, Campa MJ, Corro C, Fitzgerald MC, Patz EF Jr. (2003). Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis. Proteomics 3:1720–4.
   PubMed Web of Science ®Google Scholar
• Ihara H, Matsumoto T, Shino Y, Hashizume N, Takase M, Nagao J, Sumiyama Y. (2003). Selective use of transthyretin and retinol-binding protein as markers in the postoperative assessment of protein nutritional status. J Clin Lab Anal 17:1–5.
   PubMedGoogle Scholar
• Imanishi T. (1981). Clinical and experimental studies on the profiles of serum proteins in acute hepatic injury. Gastroenterol Jpn 16:493–505.
   PubMedGoogle Scholar
• Kaneti J, Winikoff Y, Zimlichman S, Shainkin-Kestenbaum R. (1984). Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer. Urol Res 12:239–41.
   PubMedGoogle Scholar
• Kiernan UA, Tubbs KA, Nedelkov D, Niederkofler EE, Nelson RW. (2003). Detection of novel truncated forms of human serum amyloid A protein in human plasma. FEBS Lett 537:166–70.
   PubMed Web of Science ®Google Scholar
• Kimura M, Tomita Y, Imai T, Saito T, Katagiri A, Ohara-Mikami Y, Matsudo T, Takahashi K. (2001). Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma. Cancer (Phila.) 92:2072–5.
   PubMed Web of Science ®Google Scholar
• Lim A, Prokaeva T, McComb ME, Connors LH, Skinner M, Costello CE. (2003a). Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis. Protein Sci 12:1775–85.
   PubMed Web of Science ®Google Scholar
• Lim A, Sengupta S, McComb ME, Théberge R, Wilson WG, Costello CE, Jacobsen DW. (2003b). In vitro and in vivo interactions of homocysteine with human plasma transthyretin. J Biol Chem 278:49707–13.
   PubMed Web of Science ®Google Scholar
• Liu D, Wang X, Zhang L, Dai SW, Liu L, Liu J, Wu S, Yang S, Fu S, Xiao X, He D. (2007a). Serum amyloid A protein: a potential biomarker correlated with clinical stage of lung cancer. Biomed Environ Sci 20:33–40.
   PubMed Web of Science ®Google Scholar
• Liu L, Liu J, Dai S, Wang X, Wu S, Wang J, Huang L, Xiao X, He D. (2007b). Reduced transthyretin expression in sera of lung cancer. Cancer Sci 98:1617–24.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang J, Liu B, Dai S, Wang X, Chen J, Huang L, Xiao X, He D. (2008). Serum levels of variants of transthyretin down-regulation in cholangiocarcinoma. J Cell Biochem 104:745–55.
   PubMed Web of Science ®Google Scholar
• Malle E, De Beer FC. (1996). Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 26:427–35.
   PubMed Web of Science ®Google Scholar
• Marten NW, Sladek FM, Straus DS. (1996). Effect of dietary protein restriction on liver transcription factors. Biochem J 317:361–70.
   PubMedGoogle Scholar
• Mountain CF. (1997). Revisions in the international system for staging lung cancer. Chest 111:1710–17.
   PubMed Web of Science ®Google Scholar
• Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. (2002). Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572–7.
   PubMed Web of Science ®Google Scholar
• Poon TC. (2007). Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Expert Rev Proteomics 4:51–65.
   PubMed Web of Science ®Google Scholar
• Raynes JG, Eagling S, McAdam KP. (1991). Acute-phase protein synthesis in human hepatoma cells. Differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6. Clin Exp Immunol 83:488–491.
   PubMed Web of Science ®Google Scholar
• Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. (1999). Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. Clin Lab Anal 13:273–9.
   PubMed Web of Science ®Google Scholar
• Schweigert FJ, Wirth K, Raila J. (2004). Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay. Proteome Sci 2:5.
   PubMedGoogle Scholar
• Ward DG, Cheng Y, N’Kontchou G, Thar TT, Barget N, Wei W, Billingham LJ, Martin A, Beaugrand M, Johnson PJ. (2006a). Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. Br J Cancer 94:287–92.
   PubMed Web of Science ®Google Scholar
• Ward DG, Suggett N, Cheng Y, Wei W, Johnson H, Billingham LJ, Ismail T, Wakelam MJ, Johnson PJ, Martin A. (2006b). Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer 94:1898–905.
   PubMed Web of Science ®Google Scholar
• Xiao T, Ying W, Li L, Hu Z, Ma Y, Jiao L, Ma J, Cai Y, Lin D, Guo S, Han N, Di X, Li M, Zhang D, Su K, Yuan J, Zheng H, Gao M, He J, Shi S, Li W, Xu N, Zhang H, Liu Y, Zhang K, Gao Y, Qian X, Cheng S. (2005). An approach to studying lung cancer-related proteins in human blood. Mol Cell Proteomics 4:1480–6.
   PubMed Web of Science ®Google Scholar
• Xiao X, Liu D, Tang Y, Guo F, Xia L, Liu J, He D. (2004). Development of proteomic patterns for detecting lung cancer. Dis Markers 19:33–9.
   Google Scholar
• Yamada T. (1999). Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med 37:381–8.
   PubMed Web of Science ®Google Scholar
• Yu Y, Chen S, Wang LS, Chen WL, Guo WJ, Yan H, Zhang WH, Peng CH, Zhang SD, Li HW, Chen GQ. (2005). Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification. Oncology 68:79–86.
   PubMed Web of Science ®Google Scholar